Background: Phosphoinositide 3-kinases (PI 3-kinases) are thought to play an important role in coordinating the responses elicited by a variety of growth factors, oncogene products and inflammatory stimuli. These responses include activation of membrane ruffling, chemotaxis, glucose transport, superoxide production, neurite outgrowth and pp70 S6 kinase. Some of these responses are also known to be regulated by Rac, a small GTP-binding protein related to Ras. Neither the transducing elements upstream of Rac, nor those downstream of PI 3-kinase, have been defined. Results: We show here that platelet-derived growth factor (PDGF) can stimulate an increase in the level of GTP-Rac by at least two distinct mechanisms: firstly, by increased guanine nucleotide exchange; and secondly, by inhibition of a Rac GTPase activity. The first of these mechanisms is essential for the activation of Rac, and we show that it is dependent upon PDGF-stimulated synthesis of phosphatidylinositol (3,4,5)-trisphosphate. Conclusions: These results suggest that Rac activation lies downstream of PI 3-kinase activation on a PDGFstimulated signalling pathway. Furthermore, as Rac has been implicated in at least two diverse ellular responses that are also thought to require activation of PI 3-kinasea reorganization of the actin cytoskeleton known as membrane ruffling and the neutrophil oxidative burst -these results suggest that Rac may be a major effector protein for the PI 3-kinase signalling pathway in many cell types.
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Background
Phosphoinositide 3-kinases (PI 3-kinases) catalyze the phosphorylation of the membrane phospholipid phosphatidylinositol (4,5)-bisphosphate (Ptdlns(4,5)-P 2 ) to yield Ptdlns(3,4,5)-P 3 , and are activated acutely by a variety of cell-surface growth-factor receptors, Src-type tyrosine kinases and certain G-protein-coupled receptors [1, 2] . The characteristics of this response have led to the suggestion that Ptdlns(3,4,5)-P 3 may be a new second messenger [3] [4] [5] . Recently, a number of diverse cell responses have been proposed to depend upon receptor-stimulated synthesis of this phospholipid [6] [7] [8] [9] [10] [11] [12] [13] [14] , but its direct intracellular target is still unknown and very little is currently understood of the molecular interactions that occur downstream in this pathway.
The isoform of PI 3-kinase that is known to be regulated by protein tyrosine kinases is a heterodimer composed of a tightly bound 85 kD regulatory [15] [16] [17] subunit (p85), containing two Src-homology region 2 (SH2) domains, and a 110 kD catalytic [18] subunit. The SH2 domains in p85 can bind tightly to phosphotyrosines within specific local sequences [1, 19, 20] , leading to the activation of PI 3-kinase [21, 22] . Many of these phosphorylated tyrosines -residues 740 and 751 of the platelet-derived growth factor (PGDF) 13-receptor, for example -are autophosphorylation sites in receptor protein tyrosine kinases; thus, these receptors can simultaneously recruit and activate PI 3-kinase.
Four different approaches have been employed to inhibit the activation of PI 3-kinase. First, the deletion of the specific phosphotyrosines to which the p85 subunit binds [19, 20] . Second, the use of small phosphopeptides that mimic the phosphotyrosine residues to which p85 binds [7] , which act as competitive inhibitors of the endogenous activation mechanisms. Third, overexpression of a p85 deletion mutant (Ap85) that lacks a pl10 binding site, but is still able to associate specifically with appropriate phosphotyrosines [6, 10] ; this mutant can, therefore, compete with endogenous PI 3-kinase for upstream activators. Fourth, the fungal metabolite wortmannin has been shown to bind to, and inhibit the activity of, the catalytic subunit of PI 3-kinase [12, 23, 24] . circumstantial evidence, led to the suggestion that the effects of PI 3-kinase activation are mediated via Rac [6] . We have sought to establish whether Rac is activated by PDGF, and whether this response requires PI 3-kinase-catalyzed synthesis of Ptdlns(3,4,5)-P 3 .
Results
PI 3-kinase acts upstream of Rac in PDGF-stimulated lamellipodia formation Expression vectors containing the cDNA for V12 Rac-1, a constitutively active mutant of Rac [26] , N17 Rac-1, a potentially dominant negative form of Rac [25] , or Ap85, were injected into porcine aortic endothelial (PAE) cells stably expressing either the wild-type human PDGF [3-receptor (PDGFR3-PAE cells, [8] ) or PDGF 13 receptors in which tyrosines at positions 740 and 751 are replaced with phenylalanine residues (Y740/751F-PDGFRP-PAE cells, [8] ). Wortmannin, Ap85 and N17 Rac-1 each caused a dramatic inhibition of PDGF-stimulated lamellipodia formation in PDGFRP3-PAE cells (Fig.  1) . PDGF was unable to activate PI 3-kinase [6] or lamellipodia formation in Y740/751F-PDGFR3-PAE cells (Fig. 1) . Expression of V12 Rac-1 caused extensive lamellipodia formation in both cell lines, an effect that was insensitive to wortmannin or expression of Ap85 (Fig. 1) .
These results confirm earlier work implicating both Rac and PI 3-kinase in the mechanism by which PDGF stimulates lamellipodia formation [6, 25] . However, they additionally suggest that Rac must either act downstream of, or be on a distinct pathway from, PI 3-kinase.
A PDGFRI3-PAE clone expressing epitope-tagged Rac-1 A major problem in measuring the activation of Rac in vivo has been the lack of available reagents that can be used to isolate Rac with its native complement of GTP preserved (for example, antibodies equivalent to those used to assay activation of Ras [27] ). We have attempted to circumvent this problem by deriving a number of stable, clonal PAE cell lines overexpressing an epitope -tagged form of Rac-1, Rac-l(EE) [28] . The levels of Rac-l(EE) we obtained in such cell lines were between 10-100-fold greater than that of endogenous Rac. These cell lines displayed a range of levels of lamellipodia formation, even in confluent and/or serum-starved conditions, that correlated with the extent to which they expressed Rac-l(EE) (data not shown). Even in cells expressing the lowest amounts of Rac-l(EE), roughly 60 % of the Rac-1 (EE) was recovered in membrane fractions. In contrast, less than 5 % of total Rac-1 in the parental cell line was in this fraction (Fig. 2a) .
As membrane localization has been implicated in the activation of Rac-2 in neutrophils [29, 30] , the phenotype and subcellular localization of Rac-l(EE) suggest it is at least partially active in these. cells. Consequently, two clones of PDGFR3-PAE cells expressing the least Rac-l(EE) -PDGFR13-PAE-49 and PDGFR3-PAE-144 cells -were selected for further study. In PDGFR13-PAE-49 cells, PDGF stimulated an increase in the proportion of cells displaying lamellipodia, in the number of lamellipodia per cell, and in the appearance of circular ruffles (a phenotype previously seen in wild-type cells, possibly correlated with supra-stimulation with agonists). All of these effects were inhibited by the addition of wortmannin ( Fig. 2b and legend) . Ham's F12 medium, 0.1 % BSA), challenged with either PDGF[3 (75 ng ml-1 ) or vehicle for 4 mins, and then fixed and processed to visualize actin filaments using FITC-labelled phalloidin as described previously [6] . The proportion of PDGFRP-PAE-49 cells showing edge ruffling (arrow marked E) or circular ruffles (arrow marked C) rose from 31 % (n=254) to 84% (n=169) or 0 % to 21 %, respectively, upon stimulation with PDGF. Both of these responses were inhibited by 10 min pretreatment with 100 nM wortmannin -to 36 % and 1% (n=102), respectively -although wortmannin did not significantly reduce the proportion of control cells displaying either of these phenotypes -30 % and 0 % (n=174), respectively.
PDGF stimulated a small (-1.7-fold), but highly significant, increase in the [ 32 (Figs 3a and 3b) . This response was inhibited by pretreatment of the cells with 100 nM wortmannin (Fig. 3b) . (Fig. 4a ). This response to PDGF was a result of the combined effect of a PDGFstimulated increase in the incorporation of total [
PDGF-stimulated increase in the GTP
32 p] into Rac-1(EE), particularly at earlier times of stimulation ( Fig. 4b) , and a PDGF-stimulated increase in the [ 3 2 P]GTP-Rac:
The rate of accumulation of total [ 3 2 P]Rac-1(EE) in these experiments is a measure of the rate of exchange of guanine nucleotide on Rac. The PDGF-stimulated accumulation of total [ 3 2 P]Rac-l(EE) was abolished in the presence of wortmannin ( Fig. 5b ; two minutes), and partially inhibited (by -66 %) by a doubly tyrosine phosphorylated peptide (Y-PP) based on the 20 amino-acid sequence surrounding tyrosines 740 and 751 of the human PDGF 3-receptor (Fig. 5d) . In parallel assays, wortmannin and Y-PP inhibited PDGF-stimulated Ptdlns(3,4,5)-P 3 synthesis by 80 % and 67 %, respectively (Fig. 6 ). Thus, PDGF stimulates the rate of guanine nucleotide exchange on Rac, via a mechanism that depends on PI 3-kinase-catalysed synthesis of Ptdlns(3,4,5)-P 3 . The PDGF-stimulated increase in ratio of [3 2 P]GTP: [ 3 2 P]GDP recovered on Rac-1(EE) after five minutes stimulation was substantially resistant to the presence of 100 nM wortmannin (Fig. 5c ). Hence, in the presence of wortmannin, there was a change in the ratio of GTP: GDP recovered on Rac-1(EE), without a detectable alteration in overall exchange (Fig. 5b ), indicating that PDGF had caused an inhibition of GTP hydrolysis on Rac-1(EE), and that this effect of PDGF was independent of PDGF-stimulated synthesis of Ptdlns(3,4,5)-P 3 .
Wortmannin caused a much greater inhibition of PDGF-stimulated [ 3 2 P]GTP-Rac accumulation after a two minute stimulation (-90 % inhibition; Fig. 5a ) than after a five minute stimulation (-40 % inhibition; Fig.  5a ). This is because the effect of PDGF on [ 3 2 P]GTPRac accumulation is dominated by stimulation of guanine-nucleotide exchange at earlier times, but by an inhibition of Rac-GTP hydrolysis at later times (Fig. 5b  versus Fig. 5c ). It is difficult to predict how the relative magnitudes of the two effects that we have measured in permeabilized cells relate to the situation in PDGFstimulated intact cells, but it is clear that wortmannin 
Discussion
G proteins are a large family of molecules involved in a huge variety of pathways, in which they serve as critical integrating transducers capable of delivering an on/off signal [31] . These proteins exist in either GDP-or GTPbound forms, and cycle between them as a function of their intrinsic capacity to exchange free guanine nucleotide and to hydrolyze bound GTP to GDP. However, only the GTP-bound form is recognized by effector proteins (this being the 'on' form).
Experiments carried out using site-directed mutants of Rac have helped to implicate Rac in growth-factor stimulated membrane ruffling [25] , and suggest that the GTP-bound form of Rac is indeed the likely effector conformation of this protein. Of these mutants, N17 Rac is analogous to a dominant negative mutant of Ras, and is envisaged to remain in a GDP-bound or nucleotide-free state, but to compete with wild-type Rac for a common pool of activating proteins. On the other hand, V12 Rac, which is analogous to a constitutively active mutant of Ras, has a reduced intrinsic GTPase activity and is thus believed to exist predominantly in the GTP-bound state. Our observation that PDGF stimulates an increase in the GTP content of Rac-1(EE) in PDGFR,3-PAE-49 cells, and that this response is inhibited by manipulations of PI 3-kinase activationmanipulations which also inhibit lamellipodia outgrowth, a downstream response to Rac-activation -strongly support this view.
The on/off (GTP/GDP) cycles of different G proteins are regulated in different ways. In the case of Ras proteins, two types of regulatory protein interact directly with the core G-proteins. Guanine nucleotide exchanger proteins (GEXs) accelerate nucleotide exchange and thus can, in has a very substantial potential to inhibit formation of the context of the high GTP:GDP ratio maintained in the Rac-GTP and, therefore, any downstream response cytosol, result in G-protein activation. GTPase activation which is dependent upon it.
proteins (GAPs) accelerate the rate of hydrolysis of bound GTP, and thus can cause G-protein inactivation [31] . Growth factor and antigen receptors have been shown to stimulate Ras via activation of specific GEXs [31, 32] and/or inhibition of specific GAPs [27, 31] . Similar proteins may interact with Rac and thus drive the increase in GTP-Rac that we have measured. Indeed, several Rac-GAPs -for example, Bcr, n-chimaerin, Rho GAP, p190 and the p85 subunit of PI 3-kinase [33] [34] [35] -have been defined either on the basis of their activities in vitro, or their homology to characterized proteins. But there is no evidence specifically implicating any of these proteins in growth-factor activation of Rac.
Inhibition of a putative Rac-GAP is the simplest explanation for the PDGF-stimulated, wortmannin-resistant increase in the GTP:GDP ratio recovered on Rac-1(EE) from permeabilized cells. It is uncertain, however, what type of activity may be responsible for the wortmannin-sensitive increase in guanine nucleotide exchange on Rac. This is because Rac, unlike Ras, is known to interact with a 'guanine nucleotide dissociation inhibitor' that can also bind to Rho proteins -generally referred to as RhoGDI. RhoGDI is thought to hold Rac in a GDPbound state in the cytosol and may prevent its interaction with putative GEXs [36] [37] [38] [39] [40] . In principle, it would seem that the RhoGDI-Rac complex could dissociate before, during, or after guanine nucleotide exchange on Rac. Furthermore, there are precedents, from recent studies of the regulation of Rab proteins and heterotrimeric G proteins, which suggest that either of the first two possibilities are highly plausible ( Fig. 7 and legend) . We observe that expression of Rac-1(EE), to levels substantially greater than endogenous Rac and in the absence of PDGF or serum, leads to ruffling, membrane localization of Rac and a high rate of basal nucleotide exchange on Rac-1(EE). This suggests that the presence of 'free-Rac' -caused by the overexpression of Rac relative to endogenous RhoGDI -leads to activation of Rac. Thus, the dissociation of the RhoGDI-Rac complex, rather than a direct activation of a putative Rac-GEX, may be the key step in the activation of Rac. But wortmannin prevents PDGF-stimulated nucleotide exchange on Rac-I(EE) and hence the putative dissociation of the RhoGDI-Rac complex, so why do we still see a PDGF-dependent inhibition of Rac-GTP hydrolysis in the presence of wortmannin? We suggest the explanation lies in the fact that, due to the overexpression of Rac-1(EE) there is free Rac-l(EE)-GTP in the cells, and it is the inhibition of GTP hydrolysis in this component that we observe. Clearly, this hypothesis can be tested by introducing exogenous RhoGDI into PDGFR-PAE-49 cells.
The magnitude of the GTP-Rac loading response we observe is small -1.7-times control levels in the 'intact cell' experiments -and, furthermore, this response is observed in cells expressing an epitope-tagged Rac at levels approximately 10-fold greater than its endogenous counterpart. Overexpression of Rac(EE) at these levels, it could be argued, may be sufficiently 'unphysiological' to generate experimental artifacts. However, these observations should be held in the context of similar data assessing the agonist-dependent activation of Ras. Rab proteins are relatives of Ras that can cycle between an an inactive, GDP-bound state in the cytosol and a GTP-bound state attached to specific membranes. Cytosolic Rab proteins appear to be complexed to a Rab-GDI, which inhibits their nucleotide exchange and is involved in the process of correct delivery of the Rab to its target membranes. Only subsequently, once the Rab proteins are membrane associated, do they interact with Rab-GEXs [54-561. In this model, the primary point of regulation is the splitting of the RhoGDI-Rac complex, and guanine nucleotide exchange occurs subsequently (this could occur in a regulated or non-regulated fashion and may even rely on the intrinsic guanine nucleotide exchange rate of free Rac). (b) Model based on analogy with the regulation of heterotrimeric G proteins. The core, GTP binding and hydrolyzing u subunits of heterotrimeric G-proteins appear to contain a helical subdomain which serves the role of a GDI [57, 58] . Activated cell surface receptors can bind to the basal state, GDP-bound (x3y complex in a manner that breaks the GDI-like helical domain's block on guanine nucleotide exchange [56] , hence enabling exchange of bound GDP for GTP and transition to an active conformation. The activated receptor can thus be thought of as a guanine nucleotide exchanger, and the removal of GDI-like inhibition and activation of guanine nucleotide exchange are essentially synchronous.
It is now clear, from the large number of studies addressing this issue, that there is substantial variation between different cell types responding to a single agonist, and between different agonists acting on the same cells, in their ability to stimulate accumulation of GTP-Ras. For example, PDGF has been reported to stimulate 1.5-8.0-fold increases in cellular GTP-Ras levels [27, [41] [42] [43] . This variation probably results from a combination of the distinct pathways by which receptors can regulate the activation of Ras, and the differential expression of these pathways, or their differential sensitivity to receptors [44] . Interestingly, though, substantial overexpression of wildtype Ras proteins (-30 fold over endogenous levels), does not significantly alter the ability of a given agonist to stimulate Ras-activation [43] .
Even in those situations where the level of receptorstimulated Ras activation is low -in PDGF-stimulated 3T3 cells, for example -Ras is known, on the basis of experiments using N17 Ras and Ras-neutralizing antibodies, to play a critical role in agonist-stimulated mitogenesis [45] or the activation of the MAP-kinase signalling pathway [46] . This suggests these apparently small changes in the GTP-Ras:GDP-Ras ratio are physiologically relevant. There are several possible reasons for this: the assays of Ras-activation may underestimate the scale of the response in vivo; Ras effectors may be highly sensitive to changes in the GTP-Ras:GDP-Ras balance in cells; or only a small proportion of total cellular Ras may be relevant to the receptor pathways under consideration.
Clearly, these factors suggest that the PDGF-stimulated increase in GTP-bound Rac that we report may be physiologically significant. Furthermore, several additional features, of both the regulation of Rac and the assays we adopt, indicate that it is possible we may be significantly underestimating -relative to similar estimates of Rasactivation -the extent of activation of Rac in vivo. Thus, the presence in cells of RhoGDI, the ability to bind to GDP-Rac of which may be competitively inhibited by the overexpression of epitope-tagged Rac (see above), and the fact that our epitope-tag-directed antibodies do not neutralize Rac-GTPase activity, could both result in a loss of measurable signal.
A number of independent experimental strategies all point to a critical involvement of the PI 3-kinase-catalyzed production of Ptdlns(3,4,5)-P 3 in the PDGF stimulated activation of Rac. V12 Rac can stimulate ruffling in the presence of either wortmannin or Ap85; wortmannin inhibits a PDGF-stimulated increase in the GTP content of Rac in vivo; and, in permeabilized cells, wortmannin and Y-PP inhibit PDGF-stimulated guanine nucleotide exchange on Rac. Wortmannin does not substantially inhibit PDGF-stimulated P-receptor autophosphorylation, general tyrosine phosphorylation of cell substrates or inositol phosphate production in PDGFR3-PAE cells [6] . Other workers have shown that wortmannin does not inhibit an insulin-stimulated increase in the GTPcontent of Ras [10] . Thus, it is likely that wortmannin can be used as a relatively selective tool to inhibit the hormone-stimulated synthesis of Ptdlns(3,4,5)-P 3 . In permeabilized cells, the Y-PP peptide inhibits, in parallel, both the PDGF-stimulated synthesis of Ptdlns(3,4,5)-P 3 and guanine-nucleotide exchange on Rac, whereas analogous peptides are without effect on PDGF-stimulated guanine-nucleotide exchange on Ras, in essentially identical assays [47] . Taken together, these observations provide a very strong argument that Ptdlns(3,4,5)-P 3 , directly or indirectly, stimulates guanine-nucleotide exchange on Rac, and that this mechanism is critical for the effective activation of Rac.
Recent evidence has shown that Rac-family proteins may bind to, and activate, PI 3-kinase directly [48, 49] . Taken together with the evidence reported here that PI 3-kinase activation stimulates an increase in GTP-Rac levels, this recent data may indicate the existence of feedback control within the pathway from PI 3-kinase to membrane ruffling. This is reminiscent of the reported feedback effects of calcium ions on the activity of phosphoinositidase C that have been observed in some cell types, and that have caused so much confusion in the process of defining the flow of events leading from phosphoinositidase C, via Ins(1,4,5)-P 3 , to the mobilization of calcium from intracellular stores.
Conclusions
The precise biochemical consequences of Rac activation are still poorly understood, but they are likely to involve direct Rac-activation of specific protein kinases [50] . It is easy to envisage, therefore, that Rac might adopt the role of a ubiquitous effector of the PI 3-kinase/Ptdlns(3,4,5)-P 3 signalling pathway [6] . Some evidence for the involvement of Rac in certain. specialized cell responses that are thought to depend upon PI 3-kinase activation has already been presented -for example, the involvement of Rac in the function of the neutrophil oxidase complex [51] . Our results suggest that Rac, or related small molecular weight G proteins, may also be involved in other cell responses, such as in the control of glucose transport, activation of pp70 S6 kinase and the control of neurite outgrowth. 
Materials and methods
Materials
Measurement of lamellipodia formation in PDGFRP-PAE cells injected with N17 Rac-1 and V12 Rac-1
Myc epitope-tagged cDNAs of N17 Rac-1 and V12 Rac-1 were cloned into the mammalian expression vector EXV3. PDGFRP-PAE and Y740/751F-PDGFR3-PAE cells were grown on coverslips in Ham's F12 containing 10 % FBS. The various expression plasmids were microinjected into the nucleus: V12 Rac-1 at 50 lg ml-1; N17 Rac-1 and Ap85 at 100 plg ml-1. The injected cells were serum starved for 12 hrs in a 1:1 mixture of DMEM:Ham's F12 medium supplemented with 0.1 % fatty-acid-free BSA; challenged with wortmannin (Sigma, 200 ng ml -l ) or DMSO (0.2 %) for 10 mins, and subsequently with PDGF-BB (50 ng ml-') for 2 mins. The cells were fixed and processed for FITC-phalloidin and Myc immunofluorescence, as described previously [52] .
Derivation of PDGFR[-PAE cells expressing Rac-1 (EE)
Rac-1 was tagged at the amino terminus with an EE-epitope of sequence MEFMPM (single letter amino-acid code) [28] . The cDNA encoding this hybrid protein was inserted downstream of a strong CMV1E1 promoter [6] in a mammalian expression vector conferring hygromycin resistance. Wild-type PDGFR3-PAE cells were transfected with this vector (using the calcium phosphate precipitation method) and stable clones expressing Rac-1 (EE) were selected and maintained in Ham's F12 medium containing 10 % FBS and 60 plg ml-hygromycin. Unless indicated otherwise, the clone expressing the lowest amount Rac-l(EE) -PDGFRI3-PAE-49 -was used for further study. .0 mM Hepes-NaOH, 1 mM NaHCO 3 , 0.1 % (w/v) fatty-acid-free BSA; pH 7.4 at 25 C) and then warmed to 37 C over 10 mins in this solution in the presence or absence of 120 nM wortmannin (5 ml per petri dish). Cells were then challenged at 37 C with either PDGF-BB (100 ng ml-l; added as a prewarmed aliquot of 1 ml per petri dish) or its vehicle. After a further 5 mins at 37 C, the medium was removed by aspiration and replaced with (0.8 ml per petri dish) ice-cold lysis buffer (65 mM Hepes-KOH, 1.3 % Triton X-100, 130 mM NaC1, 6.5 mM MgC1 2 , 1.2 mM DTT, 0.13 mM GTP; pH 7.5 at 0 C). The petri dishes were rocked and scraped on an ice-cold metal plate for a period of 10 min, the cell lysates were transferred to eppendorf tubes and centrifuged (11 000 rpm, 3 mins, 0 C).
Measurement of the [
A 0.8 ml aliquot of the supernatant was removed and mixed with 40 pl of SDS/deoxycholate (0.125% SDS, 12.5% deoxycholate); 160 l 1 2.5 M NaCl; and 80 ,ul 'pre-clear' beads (a 50 % slurry of protein A-sepharose saturated with mouse IgG and pre-equilibrated in lysis buffer containing 1 % BSA). The samples were packed in ice and mixed by end-over-end rotation for 5 min; the beads were then pelleted at 0 C and a 0.9 ml aliquot of the supernatant removed into tubes containing 30 l1 (packed volume) of EE-coupled beads (protein G-sepharose saturated with covalently-coupled mouse anti-EE antibody and equilibrated in lysis buffer containing 1 % BSA). The samples were packed in ice and mixed by end-over-end rotation for 30 mins, after which the beads were pelleted and washed four times with ml of ice-cold 50 mM Hepes-KOH, 5 mM MgC12, 500 mM NaCI, 0.1 % Triton X-100, 0.005 % SDS, pH 7.5 at 0 C; and then once with 1 ml of ice-cold 10 mM Hepes-KOH, 1 mM MgCl 2 , pH 7.5 at 0 C. 
Measurement of the [ 3 2 P]guanine nucleotide content of Rac-1 (EE) in permeabilized PDGFR[-PAE-49 cells
PDGFRI3-PAE-49 cells were seeded onto 35 mm petri dishes (1 105 ml-l; 2 ml per dish) and grown for 2 days in Ham's F12 medium containing 10 % FBS, 60 g ml-1 hygromycin and then serum-starved for 16 hrs in Ham's F12 medium containing 0.1 % BSA. The cells were washed in situ at 25 C with 1 x 5 ml then 1 x ml of a Hepes-buffered salts solution (25 mM Hepes-KOH, 1 mM MgCl 2 , 1 mM NaCl 2 , 132 mM NaC1, 0.1 % BSA; pH 7.4 at 25 C). This solution was then removed by aspiration and the cells permeabilized at 37 C in 1 ml (per petri) of a prewarmed buffer containing streptolysin-O (50 mM Hepes-KOH, 10 mM NaC1, 70 mM glutamate/K, 3mM MgCl2, 1.25 mM Mg-ATP, 0.29mM CaCl 2 , 1 mM EGTA/K, 0.1 % BSA, 0.4 U ml-streptolysin-O; pH 7.3 at 37 C) for 2 mins. The buffer was then removed by aspiration and replaced with an identical buffer prewarmed to 37 C containing -18 plCi ml-l [ 3 2 P]GTP and either 100 ng nml-' PDGF or diluent.
After further incubation at 37 C for the indicated periods of time, the medium was aspirated and replaced with 1 ml of ice-cold lysis buffer (50 mM Hepes-KOH, 1 % Triton X-100, 0.4 M NaCl, 5 mM MgC1 2 , 0.05 % SDS, 0.5 % deoxycholate, 0.1 mM GTP; pH 7.5 at 0 °C). The petri dishes were rocked and scraped on an ice-cold metal plate for 10 mrins and the cell lysates removed, centrifuged (11 000 rpm, 0 C, 3 mins) and 0.9 ml aliquots of the supernatant added directly to EE-coupled beads (30 aI packed volume). The samples were then processed precisely as described above for the 'intact cell' experiments except that only three washes were performed with the detergent-containing buffer. In some experiments aliquots of the [ 32 P]GTP-containing permeabilization buffer were removed, after 2-5 mins in the presence of the cells, and resolved directly on PEI cellulose: > 95% of the [ 32 p] migrated as [ 32 P]GTP. Further, in some experiments the total radioactiity in the lysates prior to immunoprecipitation was quantified; and no significant differences were found between control and PDGF-stimulated samples.
In experiments investigating the effects of wortmannin, the above protocol was followed, except that cells were warmed from 25 C to 37 C over a period of 5 mins prior to permeabilization in the Hepes-buffered salts solution in the presence or absence of 100 nM wortmahnin and then, where appropriate, 100 nM wortmannin was included in all permeabilization buffers. In experiments investigating the effects of Y-PP, 200 RIM Y-PP [53] (dissolved in permeabilization buffer) was included in all permeabilization buffers and the initial period of permeabilization -prior to the addition of PDGF (100 ng 1ml-1 32 P]GTP was omitted and the incubations were terminated by removal of the medium by aspiration and the addition of 0.5 ml ice-cold 1 M HCL. Lipid extracts were prepared, and the deacylated lipid head groups resolved ansi quantified by HPLC as described previously [4] .
Measurement of the [ 32 P]guanine nucleotide content of Rac-I (EE) after immunoprecipitation with anti-EE in vitro
Baculovirus expressed Rac-l(EE) was prepared and loaded with oe[
32 P]GTP as described previously [30] . A 200 1 aliquot containing approximately 0.5 pmol of ot [ 32 P]GTP-loaded Rac-I(EE), was added to 8 ml of the lysis buffer; and 0.8 ml aliquots of this mixture were either filtered immediately through 25 mm diameter nitrocellulose filters (defining the 'zero time' guanine nucleotide content), or immunoprecipitated, in the presence or absence, of an appropriately concentrated wild-type PAE cell lysate (as described above, for the 'intact cell' experiments). Radiolabelled [ 32 p] nucleotides were eluted from the filters, or the washed beads, and resolved by thin-layer chromatography on PEI cellulose (see above).
